Speaker / Panelist Tracking
Name | Organization | Title | Topic / Expertise | Contact Owner | Contact | Status |
---|---|---|---|---|---|---|
Stephanie Laggini Fiore | Temple University | Associate Vice Provost | - AI detectors' reliability | |||
Robin Kolodny | Temple University | Political Science Professor | - Embracing AI's potential in teaching and learning | |||
Eunsook Ha Rhee | Temple University | Associate Professor of Instruction | - AI and education teaching circles | |||
Lori Anne Salem | Temple University | Assistant Vice Provost and Director of the Student Success Center | - Faculty teaching circles on AI | |||
Hiroano Okahana | American Council on Education | Head of the Education Futures Lab | - Institutional decisions regarding chatbot use in classrooms | hokahana@acenet.edu | ||
Bill Hart-Davidson | Michigan State University | Associate Dean in MSU’s College of Arts and Letters | Strategies for modifying assignments to counter ChatGPT's capabilities | |||
Sal Khan | Khan Academy | AI Tutor | AI and education | |||
Microsoft | Github copilot? | |||||
OpenAI | ||||||
Amazon | ||||||
ex-GitHub CEO Nat Friedman | ElevenLabs (startup) | Voice intelligence | ||||
Dario Amodei | Anthropic | CEO | ||||
Clément Delangue | Hugging Face | CEO | Open-source, for-profit machine-learning platform where researchers from around the world convene to share their AI models, datasets, and best practices. | |||
Aravind Srinivas | Perplexity AI | CEO | AI chatbot and artificial intelligence-based search engine. | |||
Olivia Grace | Slack | senior director of product management | ||||
Cagatay Culcuoglu | Massive Bio Inc | co-founder and chief technology officer | Massive Bio, a biotechnology company, has introduced the use of ChatGPT in the process of recruitment for clinical trials. The company aims to use AI to improve patient engagement by using natural language processing to provide relevant responses to patient queries through a better understanding of context. Massive Bio’s chatbot can provide information on enrollment processes, details of clinical trials, and potential concerns that patients may have regarding participation, and it can match candidates who might be eligible for specific clinical trials. | |||
Luis von Ahn, Ph.D | Duolingo | CEO, consulting professor in the Computer Science Department at Carnegie Mellon University | language learning platform | |||
Copyright © 2024 The President and Fellows of Harvard College * Accessibility * Support * Request Access * Terms of Use